Centessa Pharmaceuticals plc Quarterly Depreciation in USD from Q2 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Centessa Pharmaceuticals plc quarterly/annual Depreciation history and growth rate from Q2 2021 to Q1 2024.
  • Centessa Pharmaceuticals plc Depreciation for the quarter ending March 31, 2024 was $86K, a 132% increase year-over-year.
  • Centessa Pharmaceuticals plc annual Depreciation for 2023 was $298K, a 127% increase from 2022.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $86K +$49K +132% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q1 2023 $37K +$9K +32.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q1 2022 $28K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q3 2021 $15.7K Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $5.43K Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.